Pharmacia & Upjohn 2nd quarter consumer health sales up 77% due to Nicorette, Rogaine.
This article was originally published in The Tan Sheet
PHARMACIA & UPJOHN CONSUMER HEALTHCARE SALES UP 77.4% in the second quarter to $206.8 mil. from $116.6 mil. in the prior-year period "due to the successful introduction of Nicorette gum and the hair regrowth product Rogaine into the U.S. over-the-counter market," the company announced Aug. 5. OTC Nicorette gum is marketed by SmithKline Beecham under a licensing agreement with Pharmacia & Upjohn. Both Rogaine and Nicorette were launched in April
You may also be interested in...
Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.
Mylan’s full year 2019 earnings report was its last as an independent company, so the focus was on the coming merger with Pfizer’s Upjohn and growth prospects for the new company, Viatris.
Colgate Zero toothpastes and mouthwashes promote what’s missing; Tom’s of Maine natural personal care expands with prebiotic toothpaste, deodorant and hand soap; Gaia adds hemp to its herbs; and Church & Dwight goes environmentally friendly with VitaFusion Goodness supplements, adds CBD versions to line, too.